24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CVS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:55
TikTok's US shutdown: a high-stakes game of geopolitical chess
14:18
Full list of Israeli startup M&As in 2025
14:15
Trump’s second term begins with crypto, controversy, and sweeping reforms
13:28
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
More stories
Buzz
Most popular
Daily
Weekly
1
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
2
"Wiz is the world's fastest-growing cyber company and together we can build the largest security company to come out of Israel"
3
Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million
4
Survey finds 50% of high-tech startups in Israel may exhaust funds in six months
5
"Everyone will be a manager" - what the world of work will look like with AI agents
More news
CVS
1 stories about CVS
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports
27.01.19
|
Lilach Baumer
In October, American prescription benefits management company Express Scripts added Amgen and Eli Lilly’s drugs to its coverage but excluded Teva
Please ensure Javascript is enabled for purposes of
website accessibility